RMRanganatha M. Maddakkanahalli

Ranganatha M. Maddakkanahalli

*This is an algorithmically generated author record based on publicly available information.

Ranganatha M. Maddakkanahalli has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Anil Kumar Belagal Motatis

    Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore 570006, India

    1 shared publication
  • Chandana Kumar

    Department of Chemistry, Adichunchanagiri School of Natural Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District, Karnataka 571448, India

    1 shared publication
  • Komal Jaiswal

    Department of Organic Chemistry, Indian Institute of Science (IISc), Bangalore, India

    1 shared publication
  • Muddenahalli Srinivasa Sudhanva

    Adichunchanagiri Institute for Molecular Medicine, Adichunchanagiri Institute of Medical Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District 571448, Karnataka, India

    1 shared publication
  • Shobith Rangappa

    Adichunchanagiri Institute for Molecular Medicine, Adichunchanagiri Institute of Medical Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District 571448, Karnataka, India

    1 shared publication
  • Yarabahally R. Girish

    Department of Chemistry, Adichunchanagiri School of Natural Sciences, Center for Research and Innovations, Adichunchanagiri University, B.G. Nagara Mandya District, Karnataka, India, 571448

    1 shared publication

Latest Publications

  • Engineering MoS 2 /CoSe 2 Hybrid Nanocomposites for Efficient Regeneration of Bacterially Infected Diabetic Wounds

    by Chandana Kumar, Anil Kumar Belagal Motatis, Ranganatha M. Maddakkanahalli, Komal Jaiswal, Shobith Rangappa, Sudhanva M. Srinivasa, Yarabahally R Girish

    Diabetic wounds infected with drug-resistant bacteria pose a serious global health challenge and represent a severe threat to public health. Consequently, the development of efficient and safe antibacterial agents is of great importance. In this study, MoS2/CoSe2 nanomaterials having heterojunctions were synthesized for use as a nanozyme with enhanced antibacterial activity and wound-healing applications. The MoS2/CoSe2 NC was prepared via a hydrothermal method and characterized. It displayed remarkable antibacterial action, achieving 99.71% bactericidal efficiency against Methicillin-resistant Staphylococcus aureus (MRSA). In vivo experiments in diabetic mice demonstrated that MoS2/CoSe2 significantly accelerated wound closure in MRSA-infected wounds, exhibiting excellent biocompatibility with mammalian cell lines and strong tissue-repair potential.